High Tide Inc. Common Shares (HITI) Dividend History

Company News

• High Tide Q4 Earnings: Revenue Beat, EPS Miss, Positive Free Cash Flow, Accelerating Membership Growth And More

  High Tide reported Q4 revenue of CA$138.3 million, beating estimates, but missed on EPS. The company saw accelerating growth in its membership program and generated positive free cash flow. High Tide expects to remain free cash flow positive for the rest of the fiscal year.

  Benzinga
• This Week In Cannabis: Rescheduling Delays, The DEA, Biden's Clemency, Philip Morris' New Bet And More

  The cannabis industry faces regulatory challenges, including delays in the DEA's reclassification process and scrutiny over enforcement strategies. However, there are also positive developments, such as declines in teen marijuana use in legal states and advancements in medical cannabis research and product innovation.

  Benzinga

  Featured Companies: PM
• Latest Cannabis Hires And Board Changes, Here's What You Need To Know - Benzinga

  The article discusses the latest leadership changes in the cannabis industry, including new hires and board appointments at EnWave Corporation, Virpax Pharmaceuticals, Cresco Labs, Avicanna, and High Tide.

  Benzinga
• Is aTyr Pharma (ATYR) Outperforming Other Medical Stocks This Year?

  Here is how Atyr Pharma (ATYR) and High Tide Inc. (HITI) have performed compared to their sector so far this year.

  Zacks Investment Research

  Featured Companies: ATYR
• High Tide: Higher Margins Are Now The Base Scenario

  High Tide reported Q2 results, showing slow growth, explained by underlying weaker industry sales. Learn why HITI stock is a Buy.

  Seeking Alpha